Global Gastrointestinal Cancer Drugs Market Insights and Forecast to 2031

Report ID: 1802813 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Gastrointestinal Cancer Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oncology
        1.2.3 Radiology
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Specialized Cancer Treatment Centers
        1.3.4 Clinics
        1.3.5 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gastrointestinal Cancer Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Gastrointestinal Cancer Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Gastrointestinal Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Gastrointestinal Cancer Drugs Sales by Region
        2.4.1 Global Gastrointestinal Cancer Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Gastrointestinal Cancer Drugs by Region (2023-2028)
    2.5 Global Gastrointestinal Cancer Drugs Revenue by Region
        2.5.1 Global Gastrointestinal Cancer Drugs Revenue by Region (2017-2022)
        2.5.2 Global Gastrointestinal Cancer Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gastrointestinal Cancer Drugs Sales by Manufacturers
        3.1.1 Global Top Gastrointestinal Cancer Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrointestinal Cancer Drugs in 2021
    3.2 Global Gastrointestinal Cancer Drugs Revenue by Manufacturers
        3.2.1 Global Gastrointestinal Cancer Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gastrointestinal Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Drugs Revenue in 2021
    3.3 Global Gastrointestinal Cancer Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gastrointestinal Cancer Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gastrointestinal Cancer Drugs Sales by Type
        4.1.1 Global Gastrointestinal Cancer Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Gastrointestinal Cancer Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Gastrointestinal Cancer Drugs Revenue by Type
        4.2.1 Global Gastrointestinal Cancer Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Gastrointestinal Cancer Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Gastrointestinal Cancer Drugs Price by Type
        4.3.1 Global Gastrointestinal Cancer Drugs Price by Type (2017-2022)
        4.3.2 Global Gastrointestinal Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Gastrointestinal Cancer Drugs Sales by Application
        5.1.1 Global Gastrointestinal Cancer Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Gastrointestinal Cancer Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Gastrointestinal Cancer Drugs Revenue by Application
        5.2.1 Global Gastrointestinal Cancer Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Gastrointestinal Cancer Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Gastrointestinal Cancer Drugs Price by Application
        5.3.1 Global Gastrointestinal Cancer Drugs Price by Application (2017-2022)
        5.3.2 Global Gastrointestinal Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Cancer Drugs Market Size by Type
        6.1.1 North America Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
        6.1.2 North America Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    6.2 North America Gastrointestinal Cancer Drugs Market Size by Application
        6.2.1 North America Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
        6.2.2 North America Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    6.3 North America Gastrointestinal Cancer Drugs Market Size by Country
        6.3.1 North America Gastrointestinal Cancer Drugs Sales by Country (2017-2028)
        6.3.2 North America Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Cancer Drugs Market Size by Type
        7.1.1 Europe Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
        7.1.2 Europe Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    7.2 Europe Gastrointestinal Cancer Drugs Market Size by Application
        7.2.1 Europe Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
        7.2.2 Europe Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    7.3 Europe Gastrointestinal Cancer Drugs Market Size by Country
        7.3.1 Europe Gastrointestinal Cancer Drugs Sales by Country (2017-2028)
        7.3.2 Europe Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gastrointestinal Cancer Drugs Market Size by Type
        8.1.1 Asia Pacific Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Gastrointestinal Cancer Drugs Market Size by Application
        8.2.1 Asia Pacific Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Gastrointestinal Cancer Drugs Market Size by Region
        8.3.1 Asia Pacific Gastrointestinal Cancer Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Gastrointestinal Cancer Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gastrointestinal Cancer Drugs Market Size by Type
        9.1.1 Latin America Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    9.2 Latin America Gastrointestinal Cancer Drugs Market Size by Application
        9.2.1 Latin America Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    9.3 Latin America Gastrointestinal Cancer Drugs Market Size by Country
        9.3.1 Latin America Gastrointestinal Cancer Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Type
        10.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Application
        10.2.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Gastrointestinal Cancer Drugs Market Size by Country
        10.3.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Amgen & Amgen Ireland
        11.1.1 Amgen & Amgen Ireland Corporation Information
        11.1.2 Amgen & Amgen Ireland Overview
        11.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Amgen & Amgen Ireland Recent Developments
    11.2 Bristol-Myers Squibb Company
        11.2.1 Bristol-Myers Squibb Company Corporation Information
        11.2.2 Bristol-Myers Squibb Company Overview
        11.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bristol-Myers Squibb Company Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Eli Lilly and Company
        11.4.1 Eli Lilly and Company Corporation Information
        11.4.2 Eli Lilly and Company Overview
        11.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eli Lilly and Company Recent Developments
    11.5 Johnson & Johnson Private
        11.5.1 Johnson & Johnson Private Corporation Information
        11.5.2 Johnson & Johnson Private Overview
        11.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Private Recent Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Corporation Information
        11.6.2 GlaxoSmithKline Overview
        11.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 GlaxoSmithKline Recent Developments
    11.7 Celgene Corporation
        11.7.1 Celgene Corporation Corporation Information
        11.7.2 Celgene Corporation Overview
        11.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Celgene Corporation Recent Developments
    11.8 Pfizer
        11.8.1 Pfizer Corporation Information
        11.8.2 Pfizer Overview
        11.8.3 Pfizer Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Pfizer Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Pfizer Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Corporation Information
        11.9.2 Sanofi Overview
        11.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sanofi Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sanofi Recent Developments
    11.10 Novartis
        11.10.1 Novartis Corporation Information
        11.10.2 Novartis Overview
        11.10.3 Novartis Gastrointestinal Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gastrointestinal Cancer Drugs Industry Chain Analysis
    12.2 Gastrointestinal Cancer Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gastrointestinal Cancer Drugs Production Mode & Process
    12.4 Gastrointestinal Cancer Drugs Sales and Marketing
        12.4.1 Gastrointestinal Cancer Drugs Sales Channels
        12.4.2 Gastrointestinal Cancer Drugs Distributors
    12.5 Gastrointestinal Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gastrointestinal Cancer Drugs Industry Trends
    13.2 Gastrointestinal Cancer Drugs Market Drivers
    13.3 Gastrointestinal Cancer Drugs Market Challenges
    13.4 Gastrointestinal Cancer Drugs Market Restraints
14 Key Findings in The Global Gastrointestinal Cancer Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oncology
    Table 3. Major Manufacturers of Radiology
    Table 4. Major Manufacturers of Others
    Table 5. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Gastrointestinal Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Gastrointestinal Cancer Drugs Sales by Region (2017-2022) & (K Units)
    Table 8. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2022)
    Table 9. Global Gastrointestinal Cancer Drugs Sales by Region (2023-2028) & (K Units)
    Table 10. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2023-2028)
    Table 11. Global Gastrointestinal Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2017-2022)
    Table 13. Global Gastrointestinal Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2023-2028)
    Table 15. Global Gastrointestinal Cancer Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Gastrointestinal Cancer Drugs Sales Share by Manufacturers (2017-2022)
    Table 17. Global Gastrointestinal Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Gastrointestinal Cancer Drugs Revenue Share by Manufacturers (2017-2022)
    Table 19. Gastrointestinal Cancer Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Gastrointestinal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Gastrointestinal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Drugs as of 2021)
    Table 22. Gastrointestinal Cancer Drugs Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Gastrointestinal Cancer Drugs Product Offered
    Table 24. Date of Manufacturers Enter into Gastrointestinal Cancer Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 27. Global Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 28. Global Gastrointestinal Cancer Drugs Sales Share by Type (2017-2022)
    Table 29. Global Gastrointestinal Cancer Drugs Sales Share by Type (2023-2028)
    Table 30. Global Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Gastrointestinal Cancer Drugs Revenue Share by Type (2017-2022)
    Table 33. Global Gastrointestinal Cancer Drugs Revenue Share by Type (2023-2028)
    Table 34. Gastrointestinal Cancer Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Gastrointestinal Cancer Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 37. Global Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 38. Global Gastrointestinal Cancer Drugs Sales Share by Application (2017-2022)
    Table 39. Global Gastrointestinal Cancer Drugs Sales Share by Application (2023-2028)
    Table 40. Global Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Gastrointestinal Cancer Drugs Revenue Share by Application (2017-2022)
    Table 43. Global Gastrointestinal Cancer Drugs Revenue Share by Application (2023-2028)
    Table 44. Gastrointestinal Cancer Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Gastrointestinal Cancer Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 47. North America Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 48. North America Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 51. North America Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 52. North America Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 55. North America Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 56. North America Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Gastrointestinal Cancer Drugs Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Gastrointestinal Cancer Drugs Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Amgen & Amgen Ireland Corporation Information
    Table 107. Amgen & Amgen Ireland Description and Major Businesses
    Table 108. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Amgen & Amgen Ireland Recent Developments
    Table 111. Bristol-Myers Squibb Company Corporation Information
    Table 112. Bristol-Myers Squibb Company Description and Major Businesses
    Table 113. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bristol-Myers Squibb Company Recent Developments
    Table 116. Roche Corporation Information
    Table 117. Roche Description and Major Businesses
    Table 118. Roche Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Roche Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Roche Recent Developments
    Table 121. Eli Lilly and Company Corporation Information
    Table 122. Eli Lilly and Company Description and Major Businesses
    Table 123. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Eli Lilly and Company Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Eli Lilly and Company Recent Developments
    Table 126. Johnson & Johnson Private Corporation Information
    Table 127. Johnson & Johnson Private Description and Major Businesses
    Table 128. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Johnson & Johnson Private Recent Developments
    Table 131. GlaxoSmithKline Corporation Information
    Table 132. GlaxoSmithKline Description and Major Businesses
    Table 133. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. GlaxoSmithKline Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. GlaxoSmithKline Recent Developments
    Table 136. Celgene Corporation Corporation Information
    Table 137. Celgene Corporation Description and Major Businesses
    Table 138. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Celgene Corporation Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Celgene Corporation Recent Developments
    Table 141. Pfizer Corporation Information
    Table 142. Pfizer Description and Major Businesses
    Table 143. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Pfizer Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Pfizer Recent Developments
    Table 146. Sanofi Corporation Information
    Table 147. Sanofi Description and Major Businesses
    Table 148. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Sanofi Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Sanofi Recent Developments
    Table 151. Novartis Corporation Information
    Table 152. Novartis Description and Major Businesses
    Table 153. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Novartis Gastrointestinal Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Novartis Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Gastrointestinal Cancer Drugs Distributors List
    Table 159. Gastrointestinal Cancer Drugs Customers List
    Table 160. Gastrointestinal Cancer Drugs Market Trends
    Table 161. Gastrointestinal Cancer Drugs Market Drivers
    Table 162. Gastrointestinal Cancer Drugs Market Challenges
    Table 163. Gastrointestinal Cancer Drugs Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Cancer Drugs Product Picture
    Figure 3. Global Gastrointestinal Cancer Drugs Market Share by Type in 2021 & 2028
    Figure 3. Oncology Product Picture
    Figure 4. Radiology Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Gastrointestinal Cancer Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Specialized Cancer Treatment Centers
    Figure 9. Clinics
    Figure 10. Ambulatory Surgical Centers
    Figure 11. Gastrointestinal Cancer Drugs Report Years Considered
    Figure 12. Global Gastrointestinal Cancer Drugs Sales 2017-2028 (K Units)
    Figure 13. Global Gastrointestinal Cancer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Gastrointestinal Cancer Drugs Revenue 2017-2028 (US$ Million)
    Figure 15. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2023-2028)
    Figure 18. North America Gastrointestinal Cancer Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Gastrointestinal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Gastrointestinal Cancer Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Gastrointestinal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Gastrointestinal Cancer Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Gastrointestinal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Gastrointestinal Cancer Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Gastrointestinal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Gastrointestinal Cancer Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Gastrointestinal Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Gastrointestinal Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Gastrointestinal Cancer Drugs in the World: Market Share by Gastrointestinal Cancer Drugs Revenue in 2021
    Figure 30. Global Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 32. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 33. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 34. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 36. North America Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 37. North America Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 38. North America Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Gastrointestinal Cancer Drugs Sales Share by Country (2017-2028)
    Figure 40. North America Gastrointestinal Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 41. U.S. Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 46. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Gastrointestinal Cancer Drugs Sales Share by Country (2017-2028)
    Figure 48. Europe Gastrointestinal Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 49. Germany Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. France Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Gastrointestinal Cancer Drugs Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Gastrointestinal Cancer Drugs Revenue Share by Region (2017-2028)
    Figure 60. China Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. India Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Gastrointestinal Cancer Drugs Sales Share by Country (2017-2028)
    Figure 75. Latin America Gastrointestinal Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 76. Mexico Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Gastrointestinal Cancer Drugs Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Gastrointestinal Cancer Drugs Revenue Share by Country (2017-2028)
    Figure 85. Turkey Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Gastrointestinal Cancer Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Gastrointestinal Cancer Drugs Value Chain
    Figure 89. Gastrointestinal Cancer Drugs Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen & Amgen Ireland
Bristol-Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis
Frequently Asked Questions
Gastrointestinal Cancer Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Cancer Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Cancer Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gauze Bandages

Gauze Bandages market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Gauze Swabs

Gauze Swabs market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More